The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Interventional Cardiology and Peripheral Vascular Devices-Global Market Insights and Sales Trends 2025
Synopsis
Peripheral vascular devices are a kind of devices which is used in the treatment of diseased blood vessels outside of the brain and heart. Peripheral vascular devices include peripheral vascular stents, PTA balloon catheter, embolic protection device, aortic stent graft and surgical artificial transplant.
The global Interventional Cardiology and Peripheral Vascular Devices market size is expected to reach US$ 7773 million by 2029, growing at a CAGR of 2.5% from 2023 to 2029. The market is mainly driven by the significant applications of Interventional Cardiology and Peripheral Vascular Devices in various end use industries. The expanding demands from the Hospitals, Clinics and Other, are propelling Interventional Cardiology and Peripheral Vascular Devices market. Angioplasty Balloons, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Catheters segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Interventional Cardiology and Peripheral Vascular Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Interventional Cardiology and Peripheral Vascular Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Interventional Cardiology and Peripheral Vascular Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Interventional Cardiology and Peripheral Vascular Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Interventional Cardiology and Peripheral Vascular Devices covered in this report include Medtronic, Angiomed GmbH, Abbott, Boston Scientific, Aesculap AG, Terumo Corporation, ENDOLOGIX, Cook Medical and Bolton Medical, etc.
The global Interventional Cardiology and Peripheral Vascular Devices market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Medtronic
Angiomed GmbH
Abbott
Boston Scientific
Aesculap AG
Terumo Corporation
ENDOLOGIX
Cook Medical
Bolton Medical
Jotec GmbH
Lepu
Microport
Bioteq
Global Interventional Cardiology and Peripheral Vascular Devices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Interventional Cardiology and Peripheral Vascular Devices market, Segment by Type:
Angioplasty Balloons
Catheters
Angioplasty Stents
Other
Global Interventional Cardiology and Peripheral Vascular Devices market, by Application
Hospitals
Clinics
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Interventional Cardiology and Peripheral Vascular Devices companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Peripheral vascular devices are a kind of devices which is used in the treatment of diseased blood vessels outside of the brain and heart. Peripheral vascular devices include peripheral vascular stents, PTA balloon catheter, embolic protection device, aortic stent graft and surgical artificial transplant.
The global Interventional Cardiology and Peripheral Vascular Devices market size is expected to reach US$ 7773 million by 2029, growing at a CAGR of 2.5% from 2023 to 2029. The market is mainly driven by the significant applications of Interventional Cardiology and Peripheral Vascular Devices in various end use industries. The expanding demands from the Hospitals, Clinics and Other, are propelling Interventional Cardiology and Peripheral Vascular Devices market. Angioplasty Balloons, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Catheters segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Interventional Cardiology and Peripheral Vascular Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Interventional Cardiology and Peripheral Vascular Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Interventional Cardiology and Peripheral Vascular Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Interventional Cardiology and Peripheral Vascular Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Interventional Cardiology and Peripheral Vascular Devices covered in this report include Medtronic, Angiomed GmbH, Abbott, Boston Scientific, Aesculap AG, Terumo Corporation, ENDOLOGIX, Cook Medical and Bolton Medical, etc.
The global Interventional Cardiology and Peripheral Vascular Devices market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Medtronic
Angiomed GmbH
Abbott
Boston Scientific
Aesculap AG
Terumo Corporation
ENDOLOGIX
Cook Medical
Bolton Medical
Jotec GmbH
Lepu
Microport
Bioteq
Global Interventional Cardiology and Peripheral Vascular Devices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Interventional Cardiology and Peripheral Vascular Devices market, Segment by Type:
Angioplasty Balloons
Catheters
Angioplasty Stents
Other
Global Interventional Cardiology and Peripheral Vascular Devices market, by Application
Hospitals
Clinics
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Interventional Cardiology and Peripheral Vascular Devices companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Interventional Cardiology and Peripheral Vascular Devices
1.1 Interventional Cardiology and Peripheral Vascular Devices Market Overview
1.1.1 Interventional Cardiology and Peripheral Vascular Devices Product Scope
1.1.2 Interventional Cardiology and Peripheral Vascular Devices Market Status and Outlook
1.2 Global Interventional Cardiology and Peripheral Vascular Devices Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Interventional Cardiology and Peripheral Vascular Devices Market Size by Region (2018-2029)
1.4 Global Interventional Cardiology and Peripheral Vascular Devices Historic Market Size by Region (2018-2023)
1.5 Global Interventional Cardiology and Peripheral Vascular Devices Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Interventional Cardiology and Peripheral Vascular Devices Market Size (2018-2029)
1.6.1 North America Interventional Cardiology and Peripheral Vascular Devices Market Size (2018-2029)
1.6.2 Europe Interventional Cardiology and Peripheral Vascular Devices Market Size (2018-2029)
1.6.3 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Size (2018-2029)
1.6.4 Latin America Interventional Cardiology and Peripheral Vascular Devices Market Size (2018-2029)
1.6.5 Middle East & Africa Interventional Cardiology and Peripheral Vascular Devices Market Size (2018-2029)
2 Interventional Cardiology and Peripheral Vascular Devices Market by Type
2.1 Introduction
2.1.1 Angioplasty Balloons
2.1.2 Catheters
2.1.3 Angioplasty Stents
2.1.4 Other
2.2 Global Interventional Cardiology and Peripheral Vascular Devices Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Interventional Cardiology and Peripheral Vascular Devices Historic Market Size by Type (2018-2023)
2.2.2 Global Interventional Cardiology and Peripheral Vascular Devices Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Interventional Cardiology and Peripheral Vascular Devices Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Interventional Cardiology and Peripheral Vascular Devices Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Interventional Cardiology and Peripheral Vascular Devices Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Revenue Breakdown by Type (2018-2029)
3 Interventional Cardiology and Peripheral Vascular Devices Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Other
3.2 Global Interventional Cardiology and Peripheral Vascular Devices Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Interventional Cardiology and Peripheral Vascular Devices Historic Market Size by Application (2018-2023)
3.2.2 Global Interventional Cardiology and Peripheral Vascular Devices Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Interventional Cardiology and Peripheral Vascular Devices Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Interventional Cardiology and Peripheral Vascular Devices Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Interventional Cardiology and Peripheral Vascular Devices Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Revenue Breakdown by Application (2018-2029)
4 Interventional Cardiology and Peripheral Vascular Devices Competition Analysis by Players
4.1 Global Interventional Cardiology and Peripheral Vascular Devices Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Interventional Cardiology and Peripheral Vascular Devices as of 2022)
4.3 Date of Key Players Enter into Interventional Cardiology and Peripheral Vascular Devices Market
4.4 Global Top Players Interventional Cardiology and Peripheral Vascular Devices Headquarters and Area Served
4.5 Key Players Interventional Cardiology and Peripheral Vascular Devices Product Solution and Service
4.6 Competitive Status
4.6.1 Interventional Cardiology and Peripheral Vascular Devices Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Medtronic
5.1.1 Medtronic Profile
5.1.2 Medtronic Main Business
5.1.3 Medtronic Interventional Cardiology and Peripheral Vascular Devices Products, Services and Solutions
5.1.4 Medtronic Interventional Cardiology and Peripheral Vascular Devices Revenue (US$ Million) & (2018-2023)
5.1.5 Medtronic Recent Developments
5.2 Angiomed GmbH
5.2.1 Angiomed GmbH Profile
5.2.2 Angiomed GmbH Main Business
5.2.3 Angiomed GmbH Interventional Cardiology and Peripheral Vascular Devices Products, Services and Solutions
5.2.4 Angiomed GmbH Interventional Cardiology and Peripheral Vascular Devices Revenue (US$ Million) & (2018-2023)
5.2.5 Angiomed GmbH Recent Developments
5.3 Abbott
5.3.1 Abbott Profile
5.3.2 Abbott Main Business
5.3.3 Abbott Interventional Cardiology and Peripheral Vascular Devices Products, Services and Solutions
5.3.4 Abbott Interventional Cardiology and Peripheral Vascular Devices Revenue (US$ Million) & (2018-2023)
5.3.5 Boston Scientific Recent Developments
5.4 Boston Scientific
5.4.1 Boston Scientific Profile
5.4.2 Boston Scientific Main Business
5.4.3 Boston Scientific Interventional Cardiology and Peripheral Vascular Devices Products, Services and Solutions
5.4.4 Boston Scientific Interventional Cardiology and Peripheral Vascular Devices Revenue (US$ Million) & (2018-2023)
5.4.5 Boston Scientific Recent Developments
5.5 Aesculap AG
5.5.1 Aesculap AG Profile
5.5.2 Aesculap AG Main Business
5.5.3 Aesculap AG Interventional Cardiology and Peripheral Vascular Devices Products, Services and Solutions
5.5.4 Aesculap AG Interventional Cardiology and Peripheral Vascular Devices Revenue (US$ Million) & (2018-2023)
5.5.5 Aesculap AG Recent Developments
5.6 Terumo Corporation
5.6.1 Terumo Corporation Profile
5.6.2 Terumo Corporation Main Business
5.6.3 Terumo Corporation Interventional Cardiology and Peripheral Vascular Devices Products, Services and Solutions
5.6.4 Terumo Corporation Interventional Cardiology and Peripheral Vascular Devices Revenue (US$ Million) & (2018-2023)
5.6.5 Terumo Corporation Recent Developments
5.7 ENDOLOGIX
5.7.1 ENDOLOGIX Profile
5.7.2 ENDOLOGIX Main Business
5.7.3 ENDOLOGIX Interventional Cardiology and Peripheral Vascular Devices Products, Services and Solutions
5.7.4 ENDOLOGIX Interventional Cardiology and Peripheral Vascular Devices Revenue (US$ Million) & (2018-2023)
5.7.5 ENDOLOGIX Recent Developments
5.8 Cook Medical
5.8.1 Cook Medical Profile
5.8.2 Cook Medical Main Business
5.8.3 Cook Medical Interventional Cardiology and Peripheral Vascular Devices Products, Services and Solutions
5.8.4 Cook Medical Interventional Cardiology and Peripheral Vascular Devices Revenue (US$ Million) & (2018-2023)
5.8.5 Cook Medical Recent Developments
5.9 Bolton Medical
5.9.1 Bolton Medical Profile
5.9.2 Bolton Medical Main Business
5.9.3 Bolton Medical Interventional Cardiology and Peripheral Vascular Devices Products, Services and Solutions
5.9.4 Bolton Medical Interventional Cardiology and Peripheral Vascular Devices Revenue (US$ Million) & (2018-2023)
5.9.5 Bolton Medical Recent Developments
5.10 Jotec GmbH
5.10.1 Jotec GmbH Profile
5.10.2 Jotec GmbH Main Business
5.10.3 Jotec GmbH Interventional Cardiology and Peripheral Vascular Devices Products, Services and Solutions
5.10.4 Jotec GmbH Interventional Cardiology and Peripheral Vascular Devices Revenue (US$ Million) & (2018-2023)
5.10.5 Jotec GmbH Recent Developments
5.11 Lepu
5.11.1 Lepu Profile
5.11.2 Lepu Main Business
5.11.3 Lepu Interventional Cardiology and Peripheral Vascular Devices Products, Services and Solutions
5.11.4 Lepu Interventional Cardiology and Peripheral Vascular Devices Revenue (US$ Million) & (2018-2023)
5.11.5 Lepu Recent Developments
5.12 Microport
5.12.1 Microport Profile
5.12.2 Microport Main Business
5.12.3 Microport Interventional Cardiology and Peripheral Vascular Devices Products, Services and Solutions
5.12.4 Microport Interventional Cardiology and Peripheral Vascular Devices Revenue (US$ Million) & (2018-2023)
5.12.5 Microport Recent Developments
5.13 Bioteq
5.13.1 Bioteq Profile
5.13.2 Bioteq Main Business
5.13.3 Bioteq Interventional Cardiology and Peripheral Vascular Devices Products, Services and Solutions
5.13.4 Bioteq Interventional Cardiology and Peripheral Vascular Devices Revenue (US$ Million) & (2018-2023)
5.13.5 Bioteq Recent Developments
6 North America
6.1 North America Interventional Cardiology and Peripheral Vascular Devices Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Interventional Cardiology and Peripheral Vascular Devices Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Interventional Cardiology and Peripheral Vascular Devices Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Interventional Cardiology and Peripheral Vascular Devices Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Interventional Cardiology and Peripheral Vascular Devices Market Dynamics
11.1 Interventional Cardiology and Peripheral Vascular Devices Industry Trends
11.2 Interventional Cardiology and Peripheral Vascular Devices Market Drivers
11.3 Interventional Cardiology and Peripheral Vascular Devices Market Challenges
11.4 Interventional Cardiology and Peripheral Vascular Devices Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
